4//SEC Filing
Bachrodt Amy 4
Accession 0002050422-25-000004
CIK 0001842295other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 4:23 PM ET
Size
5.8 KB
Accession
0002050422-25-000004
Insider Transaction Report
Form 4
Bachrodt Amy
SVP, Finance
Transactions
- Award
Restricted Stock Units
2025-09-22+22,000→ 22,000 total→ Common Stock (22,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F2]The award shall vest as to 1/2 of the total award on September 1, 2026 and September 1, 2027, subject to the reporting person's continued service to the Issuer on each vesting date.
- [F3]These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.
Documents
Issuer
Maze Therapeutics, Inc.
CIK 0001842295
Entity typeother
Related Parties
1- filerCIK 0002050422
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 4:23 PM ET
- Size
- 5.8 KB